NCT04561193View on ClinicalTrials.gov

Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)

CompletedOBSERVATIONAL
Enrollment

417

Participants

Timeline

Start Date

May 30, 2020

Primary Completion Date

May 23, 2022

Study Completion Date

May 23, 2022

Conditions
COVID-19
Interventions
OTHER

Observational

Observational

Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER

NCT04561193 - Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19) | Biotech Hunter | Biotech Hunter